286 related articles for article (PubMed ID: 20194497)
1. TEAD-1 overexpression in the mouse heart promotes an age-dependent heart dysfunction.
Tsika RW; Ma L; Kehat I; Schramm C; Simmer G; Morgan B; Fine DM; Hanft LM; McDonald KS; Molkentin JD; Krenz M; Yang S; Ji J
J Biol Chem; 2010 Apr; 285(18):13721-35. PubMed ID: 20194497
[TBL] [Abstract][Full Text] [Related]
2. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
[TBL] [Abstract][Full Text] [Related]
3. The chromatin-binding protein Smyd1 restricts adult mammalian heart growth.
Franklin S; Kimball T; Rasmussen TL; Rosa-Garrido M; Chen H; Tran T; Miller MR; Gray R; Jiang S; Ren S; Wang Y; Tucker HO; Vondriska TM
Am J Physiol Heart Circ Physiol; 2016 Nov; 311(5):H1234-H1247. PubMed ID: 27663768
[TBL] [Abstract][Full Text] [Related]
4. Cardiac-restricted Overexpression of TRAF3 Interacting Protein 2 (TRAF3IP2) Results in Spontaneous Development of Myocardial Hypertrophy, Fibrosis, and Dysfunction.
Yariswamy M; Yoshida T; Valente AJ; Kandikattu HK; Sakamuri SS; Siddesha JM; Sukhanov S; Saifudeen Z; Ma L; Siebenlist U; Gardner JD; Chandrasekar B
J Biol Chem; 2016 Sep; 291(37):19425-36. PubMed ID: 27466370
[TBL] [Abstract][Full Text] [Related]
5. The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice.
Kim Y; Phan D; van Rooij E; Wang DZ; McAnally J; Qi X; Richardson JA; Hill JA; Bassel-Duby R; Olson EN
J Clin Invest; 2008 Jan; 118(1):124-32. PubMed ID: 18079970
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of TEAD-1 in transgenic mouse striated muscles produces a slower skeletal muscle contractile phenotype.
Tsika RW; Schramm C; Simmer G; Fitzsimons DP; Moss RL; Ji J
J Biol Chem; 2008 Dec; 283(52):36154-67. PubMed ID: 18978355
[TBL] [Abstract][Full Text] [Related]
7. Wnt signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling.
Malekar P; Hagenmueller M; Anyanwu A; Buss S; Streit MR; Weiss CS; Wolf D; Riffel J; Bauer A; Katus HA; Hardt SE
Hypertension; 2010 Apr; 55(4):939-45. PubMed ID: 20177000
[TBL] [Abstract][Full Text] [Related]
8. Serum response factor neutralizes Pur alpha- and Pur beta-mediated repression of the fetal vascular smooth muscle alpha-actin gene in stressed adult cardiomyocytes.
Zhang A; David JJ; Subramanian SV; Liu X; Fuerst MD; Zhao X; Leier CV; Orosz CG; Kelm RJ; Strauch AR
Am J Physiol Cell Physiol; 2008 Mar; 294(3):C702-14. PubMed ID: 18344281
[TBL] [Abstract][Full Text] [Related]
9. The extracellular matrix proteoglycan fibromodulin is upregulated in clinical and experimental heart failure and affects cardiac remodeling.
Andenæs K; Lunde IG; Mohammadzadeh N; Dahl CP; Aronsen JM; Strand ME; Palmero S; Sjaastad I; Christensen G; Engebretsen KVT; Tønnessen T
PLoS One; 2018; 13(7):e0201422. PubMed ID: 30052659
[TBL] [Abstract][Full Text] [Related]
10. The scaffold protein muscle A-kinase anchoring protein β orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure.
Kritzer MD; Li J; Passariello CL; Gayanilo M; Thakur H; Dayan J; Dodge-Kafka K; Kapiloff MS
Circ Heart Fail; 2014 Jul; 7(4):663-72. PubMed ID: 24812305
[TBL] [Abstract][Full Text] [Related]
11. Interferon regulatory factor 1 is required for cardiac remodeling in response to pressure overload.
Jiang DS; Li L; Huang L; Gong J; Xia H; Liu X; Wan N; Wei X; Zhu X; Chen Y; Chen X; Zhang XD; Li H
Hypertension; 2014 Jul; 64(1):77-86. PubMed ID: 24732887
[TBL] [Abstract][Full Text] [Related]
12. Talin1 has unique expression versus talin 2 in the heart and modifies the hypertrophic response to pressure overload.
Manso AM; Li R; Monkley SJ; Cruz NM; Ong S; Lao DH; Koshman YE; Gu Y; Peterson KL; Chen J; Abel ED; Samarel AM; Critchley DR; Ross RS
J Biol Chem; 2013 Feb; 288(6):4252-64. PubMed ID: 23266827
[TBL] [Abstract][Full Text] [Related]
13. Essential role of stress hormone signaling in cardiomyocytes for the prevention of heart disease.
Oakley RH; Ren R; Cruz-Topete D; Bird GS; Myers PH; Boyle MC; Schneider MD; Willis MS; Cidlowski JA
Proc Natl Acad Sci U S A; 2013 Oct; 110(42):17035-40. PubMed ID: 24082121
[TBL] [Abstract][Full Text] [Related]
14. The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis.
Yoon PO; Lee MA; Cha H; Jeong MH; Kim J; Jang SP; Choi BY; Jeong D; Yang DK; Hajjar RJ; Park WJ
J Mol Cell Cardiol; 2010 Aug; 49(2):294-303. PubMed ID: 20430035
[TBL] [Abstract][Full Text] [Related]
15. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
[TBL] [Abstract][Full Text] [Related]
16. RhoGEF12 controls cardiac remodeling by integrating G protein- and integrin-dependent signaling cascades.
Takefuji M; Krüger M; Sivaraj KK; Kaibuchi K; Offermanns S; Wettschureck N
J Exp Med; 2013 Apr; 210(4):665-73. PubMed ID: 23530122
[TBL] [Abstract][Full Text] [Related]
17. The role of SUMO-1 in cardiac oxidative stress and hypertrophy.
Lee A; Jeong D; Mitsuyama S; Oh JG; Liang L; Ikeda Y; Sadoshima J; Hajjar RJ; Kho C
Antioxid Redox Signal; 2014 Nov; 21(14):1986-2001. PubMed ID: 24893265
[TBL] [Abstract][Full Text] [Related]
18. Prdm16 Deficiency Leads to Age-Dependent Cardiac Hypertrophy, Adverse Remodeling, Mitochondrial Dysfunction, and Heart Failure.
Cibi DM; Bi-Lin KW; Shekeran SG; Sandireddy R; Tee N; Singh A; Wu Y; Srinivasan DK; Kovalik JP; Ghosh S; Seale P; Singh MK
Cell Rep; 2020 Oct; 33(3):108288. PubMed ID: 33086060
[TBL] [Abstract][Full Text] [Related]
19. Ablation of mineralocorticoid receptors in myocytes but not in fibroblasts preserves cardiac function.
Lother A; Berger S; Gilsbach R; Rösner S; Ecke A; Barreto F; Bauersachs J; Schütz G; Hein L
Hypertension; 2011 Apr; 57(4):746-54. PubMed ID: 21321305
[TBL] [Abstract][Full Text] [Related]
20. STEAP3 (Six-Transmembrane Epithelial Antigen of Prostate 3) Inhibits Pathological Cardiac Hypertrophy.
Li PL; Liu H; Chen GP; Li L; Shi HJ; Nie HY; Liu Z; Hu YF; Yang J; Zhang P; Zhang XJ; She ZG; Li H; Huang Z; Zhu L
Hypertension; 2020 Oct; 76(4):1219-1230. PubMed ID: 32862709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
